Print Page | Contact Us | Report Abuse | Sign In | Register
Workshop: Medication Assisted Treatment for Special Populations: Whos, Whys & Hows of Access for All
Tell a Friend About This EventTell a Friend
 

This workshop is relevant to a variety of health and human service professionals and paraprofessionals, such as health care professionals (physicians, pharmacists, nurses, emergency medical peronnel, etc.), law enforcement, mental health and addiction professionals, behavioral health technicians, recovery support personnel, and community members at risk of experiencing or witnessing an opioid overdose.

4/26/2018
When: April 26, 2018
9:00 am to 4:00 pm, EST
Where: Hilton Garden Inn Sea World
6850 Westwood Boulevard
Orlando, Florida  32821
United States
Presenter: David R. Gastfriend, MD
Contact: Vanessa Addison
850-878-2196


Online registration is closed.
« Go to Upcoming Event List  

Although the opioid epidemic is killing a broad swath of Americans, there are important subgroups who are at even greater risk. Their vulnerability and specific needs deserve particular attention. Medication in addiction treatment selection and delivery must be considered in light of these epidemiologic, biological and other clinical parameters. Focused attention to outreach, wrap-around services and collaborative care can save lives and build recovery and health for these patients, their communities, and society as a whole. 

Who should attend?
This workshop is relevant to a variety of health and human service professionals and paraprofessionals, such as health care professionals (physicians, pharmacists, nurses, emergency medical peronnel, etc.), law enforcement, mental health and addiction professionals, behavioral health technicians, recovery support personnel, and community members at risk of experiencing or witnessing an opioid overdose.
Presented by:
David Gastfriend, MD, is Senior Research Scientist at the Treatment Research Institute (TRI). An addiction psychiatrist, he directed addiction research at Massachusetts General Hospital and was an investigator in the NIDA Cocaine Collaborative Study, the NIAAA COMBINE Study and the NIDA Clinical Trials Network. As Vice President at Alkermes, Inc., Dr. Gastfriend conducted biological, clinical, health economics and policy research on behalf of the company’s efforts in the field of addiction treatment. For 25 years, Dr. Gastfriend served on the faculty of Harvard Medical School, notably as the Director of the Addiction Research Program at Massachusetts General Hospital and founder of the MGH/McLean Hospital Fellowship in Addiction Psychiatry. He is considered the world’s leading expert on two important treatment tools from both the biological and psychosocial realms: the opioid blocker Vivitrol, and the American Society of Addiction Medicine (ASAM) Criteria Software.

CEUs:
5.5 Continuing Education Units/Contact Hours are provided for this event
Florida Certification Board Recognized Education Provider
Florida Board of Social Work, Marriage and Family Therapy and Mental Health Counseling Provider #50-676
Florida Board of Nursing Provider #50-676